Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease.

Added 3101 days ago (28.03.2013)
Authors: Bäck S, Peränen J, Galli E, Pulkkila P, Lonka-Nevalaita L, Tamminen T, Voutilainen MH, Raasmaja A, Saarma M, Männistö PT, Tuominen RK
PubMed id: 23532969
Read article